52000

🩺 CPT 52000: Cystourethroscopy (Separate Procedure)

Diagnostic cystoscopy (urethra + bladder endoscopic visualization)

Last Updated: February 2026
Status: Medicare global-package rules referenced; fee amounts shown as Medicare unadjusted national averages where noted (verify your MAC/locality)
Specialty Tags: urology endoscopy diagnostic cystoscopy

---

Quick reference

Element	Details
CPT code	52000
Long descriptor (summary)	Cystourethroscopy (separate procedure)
Procedure type	Diagnostic cystoscopy (urethra + bladder endoscopic visualization)
Typical POS	Office (11), Outpatient hospital (22), ASC (24)
Global period	000 (0-day); global surgery rules apply on the procedure date (verify in MPFS for your year/MAC)
wRVU (work RVU)	Pull from CMS MPFS Look-Up for your year (I’m not listing a number here because it must match the current MPFS RVU file for your date of service/locality)
Total RVUs & sample Medicare physician allow (example)	2026 unadjusted national averages shown in a cystoscopy payment guide: Facility total RVUs 2.13 / $71\ast \ast ,\ast \ast OfficetotalRVUs6.46/$216
Hospital outpatient / ASC facility allow (example)	2026 unadjusted national averages (facility payment): APC 5372, status indicator J1; HOPD $712\ast \ast ,\ast \ast ASC$311

---

📋 Short definition

CPT 52000 reports a diagnostic cystourethroscopy (endoscopic examination of the urethra and bladder) performed as a standalone (“separate procedure”) service when no more definitive cystoscopic procedure is performed at the same session.

---

Long definition

Cystourethroscopy is performed by passing a cystoscope through the urethra into the bladder to directly visualize the urethral lumen, bladder mucosa, trigone, bladder neck, and ureteral orifices (as clinically appropriate) to evaluate urinary symptoms and/or abnormalities.

Typical indications (medical necessity must be explicit):

• Hematuria evaluation (gross or microscopic), especially when bladder source is suspected (tumor, stone, inflammation).
• Recurrent UTI/irritative voiding symptoms to evaluate for anatomic causes (e.g., stones, foreign body, malignancy, diverticula).
• Suspected bladder outlet obstruction/urethral pathology (e.g., stricture) when endoscopic assessment is clinically needed.
• Surveillance in patients with prior bladder cancer when cystoscopy is part of their follow-up plan.

What 52000 generally includes (when performed and documented):

• Scope insertion and systematic inspection of urethra and bladder.
• Findings documentation (normal vs abnormal mucosa, lesions, stones, trabeculation, erythema, strictures).
• Basic bladder irrigation only as needed for visualization (not the same as clot evacuation work in 52001).

What 52000 is not (common “don’t accidentally undercode” situations):

• If the physician performs a more extensive cystoscopic procedure (biopsy, fulguration, tumor resection, stent removal, ureteral catheterization, etc.), the “separate procedure” cystoscopy is typically not billed separately because the cystoscopy is inherent to the larger service.

---

Fee schedule & RVU notes (Medicare)

Physician payment (professional)

A cystoscopy coding/payment guide lists 2026 Medicare unadjusted national averages for CPT 52000 as $71in-facility(2.13totalfacilityRVUs)\ast \ast and\ast \ast$216 in-office (6.46 total office RVUs). Use these as benchmarking only; actual payment is locality-adjusted and year-specific, and the official source is the CMS MPFS look-up/RVU file.

Facility payment (HOPD/ASC)

The same guide lists 2026 unadjusted national averages for the facility side under OPPS/ASC: APC 5372, status indicator J1, with HOPD $712\ast \ast and\ast \ast ASC$311. Remember: these are facility allowed amounts (not physician professional payment) and may be packaged per OPPS rules for that APC/status.

---

Global period (000) + Medicare rules (practical)

Global period 000 basics: procedures with a 0-day global have no postoperative days included, but Medicare generally considers the visit on the procedure day part of the global package unless a significant, separately identifiable E/M is provided. If you bill an E/M on the same date as 52000, use modifier -25 on the E/M only when documentation supports a significant, separately identifiable service beyond the usual pre/post work of the procedure.

“Separate procedure” rule (big compliance point): because 52000 is designated a separate procedure, it is typically not separately reportable when it is performed as an integral component of a more extensive urologic endoscopy done at the same session. When claims include 52000 plus a therapeutic cystoscopic CPT, expect bundling edits unless there is a truly distinct circumstance (rare; must be well documented and may still be denied depending on NCCI/ payer edits).

No specific NCD: There is not typically a cystoscopy-specific National Coverage Determination; coverage is generally based on medical necessity and any applicable MAC LCD guidance for the underlying condition/symptom.

---

Common modifiers (what you’ll actually use)

E/M-related

• -25 (E/M only): Significant, separately identifiable E/M on the same day as the procedure (most common modifier scenario for office cystoscopy).

Distinct procedural circumstances (use carefully)

• -59 / X{EPSU}: Distinct procedural service when allowed by payer edits and supported by documentation (separate lesion/site, separate encounter, etc.); do not use just to “break a bundle.”
• -52: Reduced services (e.g., procedure started but substantially reduced and documented).
• -53: Discontinued procedure (e.g., procedure stopped due to patient safety/complication; document why).
• -76 / -77: Repeat procedure (same physician / another physician) when truly repeated.
• -TC / -26: Not typical for 52000 (no separate professional/technical split like imaging), but include only if your payer specifically instructs for unusual scenarios.

Global split-care (rare for office cystoscopy)

• -54 / -55 / -56: For formal transfer of surgical care components when applicable under Medicare rules.

---

Documentation checklist (audit-friendly)

Pre-procedure

• Clear indication/medical necessity today (symptoms + risk factors + prior workup).
• Pertinent history (hematuria details, UTI history, stone history, cancer history, prior instrumentation).
• Urinalysis/culture results when relevant; pregnancy status when relevant.
• Informed consent (risks: infection, bleeding, dysuria, urinary retention, discomfort, need for further procedures).

Procedure note (key elements)

• Scope type (flexible vs rigid) and anesthesia used (topical, local, sedation—if documented).
• Extent of exam: urethra + bladder survey; whether ureteral orifices visualized.
• Findings: normal/abnormal, lesion description (size/location), stones, trabeculation, strictures, erythema, diverticula, clots.
• If a lesion is seen but no biopsy/fulguration performed: document why (plan for OR TURBT, anticoagulation, need imaging first, etc.).
• Complications (none vs specifics) and patient tolerance.
• Disposition and follow-up plan.

Post-procedure

• Expected symptoms counseling (dysuria, mild hematuria).
• When to call/return (fever, inability to void, heavy bleeding/clots).
• Antibiotic use per practice protocol (document if given and why).

---

ICD-10-CM (common medical-necessity diagnoses)

Pick the most specific code supported by documentation (including etiology, laterality when applicable, and cancer history vs active disease).

Hematuria

• R31.0 Gross hematuria
• R31.29 Other microscopic hematuria
• R31.9 hematuria, unspecified

UTI / cystitis

• N39.0 Urinary tract infection, site not specified
• N30.00 Acute cystitis without hematuria
• N30.01 Acute cystitis with hematuria

Lower urinary tract symptoms

• R33.9 Retention of urine, unspecified
• R39.14 Feeling of incomplete bladder emptying
• R39.15 Urgency of urination
• R35.0 Frequency of micturition
• R30.0 Dysuria

Malignancy / history

• C67.0-C67.9 Malignant neoplasm of bladder (site-specific)
• Z85.51 Personal history of malignant neoplasm of bladder
• D49.4 Neoplasm of unspecified behavior of bladder (use only if documentation truly supports “uncertain behavior” workup)

Stones / obstruction (when cystoscopy is part of evaluation)

• N20.0 Calculus of kidney
• N20.1 Calculus of ureter
• N32.0 Bladder-neck obstruction
• N35.9 Urethral stricture, unspecified

Coding tip: If cystoscopy is done as part of a hematuria workup, ensure the record supports why direct visualization was needed (e.g., persistent hematuria, risk factors, abnormal imaging, prior bladder cancer).

---

Common bundling/“don’t bill 52000 with…” examples

Because 52000 is a separate procedure, it is usually included when you perform more definitive cystoscopic procedures in the same session (examples: biopsy/fulguration/TURBT/ureteral catheterization). When documentation supports only diagnostic visualization without additional therapeutic/diagnostic cystoscopic work, 52000 is appropriate as the primary service.

---

References (for your compliance binder)

• Cystoscopy coding/payment guide showing 52000 descriptor and example national average payments/RVUs (2026).
• CMS MLN Global Surgery booklet (modifier -25, global package concepts).
• Noridian summary of global period concepts (000/010/090 overview).
• CMS NCCI Policy Manual discussion of “separate procedure” reporting principles.